Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anette Hall

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Neuro-Degenerative Diseases|August 24, 2013
Comparing predictors of conversion to Alzheimer's disease using the disease state indexMiguel Ángel Muñoz-Ruiz, Anette Hall, Jussi Mattila, et al.
The Journal of Prevention of Alzheimer'S Disease|January 16, 2026
Preparing for the implementation of anti-amyloid therapies in Europe: Assessing real-world eligibility for lecanemab and donanemab in a Swedish memory clinicAnna Rosenberg, Alina Solomon, Alexandre Bonnard, et al.
Neuro-Degenerative Diseases|December 16, 2014
The effect of TOMM40 poly-T repeat lengths on age of onset and cerebrospinal fluid biomarkers in Finnish Alzheimer's disease patientsSeppo Helisalmi, Anette Hall, Esa-Heikki Meriläinen, et al.
European Journal of Neurology|August 12, 2024
Brain amyloid load, subjective memory complaints, and cognitive trajectories in older individuals at risk for dementiaGazi Saadmaan, Anette Hall, Tiia Ngandu, et al.
Journal of Alzheimer'S Disease : JAD|July 6, 2020
Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of DementiaTimo Pekkala, Anette Hall, Francesca Mangialasche, et al.
Neurology|September 21, 2022
β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic PopulationAnna Rosenberg, Ulf Öhlund-Wistbacka, Anette Hall, et al.
Annals of Clinical and Translational Neurology|May 23, 2020
Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosisAntti Cajanus, Kasper Katisko, Aleksi Kontkanen, et al.
Journal of Alzheimer'S Disease : JAD|March 5, 2013
Disease state fingerprint in frontotemporal degeneration with reference to Alzheimer's disease and mild cognitive impairmentMiguel Ángel Muñoz-Ruiz, Päivi Hartikainen, Anette Hall, et al.
Journal of Alzheimer'S Disease : JAD|September 10, 2014
Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's diseaseAnette Hall, Miguel Muñoz-Ruiz, Jussi Mattila, et al.
European Journal of Neurology|February 7, 2024
The Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) score as a predictor for cognitive decline and potential surrogate outcome in the FINGER lifestyle randomized controlled trialAnette Hall, Mariagnese Barbera, Jenni Lehtisalo, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Neuro-Degenerative Diseases|August 24, 2013
Comparing predictors of conversion to Alzheimer's disease using the disease state indexMiguel Ángel Muñoz-Ruiz, Anette Hall, Jussi Mattila, et al.
The Journal of Prevention of Alzheimer'S Disease|January 16, 2026
Preparing for the implementation of anti-amyloid therapies in Europe: Assessing real-world eligibility for lecanemab and donanemab in a Swedish memory clinicAnna Rosenberg, Alina Solomon, Alexandre Bonnard, et al.
Neuro-Degenerative Diseases|December 16, 2014
The effect of TOMM40 poly-T repeat lengths on age of onset and cerebrospinal fluid biomarkers in Finnish Alzheimer's disease patientsSeppo Helisalmi, Anette Hall, Esa-Heikki Meriläinen, et al.
European Journal of Neurology|August 12, 2024
Brain amyloid load, subjective memory complaints, and cognitive trajectories in older individuals at risk for dementiaGazi Saadmaan, Anette Hall, Tiia Ngandu, et al.
Journal of Alzheimer'S Disease : JAD|July 6, 2020
Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of DementiaTimo Pekkala, Anette Hall, Francesca Mangialasche, et al.
Neurology|September 21, 2022
β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic PopulationAnna Rosenberg, Ulf Öhlund-Wistbacka, Anette Hall, et al.
Annals of Clinical and Translational Neurology|May 23, 2020
Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosisAntti Cajanus, Kasper Katisko, Aleksi Kontkanen, et al.
Journal of Alzheimer'S Disease : JAD|March 5, 2013
Disease state fingerprint in frontotemporal degeneration with reference to Alzheimer's disease and mild cognitive impairmentMiguel Ángel Muñoz-Ruiz, Päivi Hartikainen, Anette Hall, et al.
Journal of Alzheimer'S Disease : JAD|September 10, 2014
Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's diseaseAnette Hall, Miguel Muñoz-Ruiz, Jussi Mattila, et al.
European Journal of Neurology|February 7, 2024
The Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) score as a predictor for cognitive decline and potential surrogate outcome in the FINGER lifestyle randomized controlled trialAnette Hall, Mariagnese Barbera, Jenni Lehtisalo, et al.
Pageof 4